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We examined the effect of thyrotropin (TSH) on intracellular levels of c-ras mRNA in a line of differentiated 
rat thyroid cells obtained from normal Fischer rat thyroids. These cells are totally dependent on TSH for 
growth. TSH stimulation of quiescent cells increased c-ras mRNA content, with a maximal response (730% 
of basal) after 6 h, and a decline towards basal levels after 24 h. Dibutyryl CAMP and forskolin mimicked 
this stimulatory effect of TSH on c-ras, but did not enhance /I-actin mRNA content. This study demon- 
strates hormonal and cyclic nucleotide control of c-ras expression in a well-differentiated, non-tumorogenic 
mammalian cell. 
Thyroid Thyrotropin 
1. INTRODUCTION 
Recent data suggest an important role for on- 
cogene expression in cellular growth [ 11. Transfor- 
ming, or viral, oncogenes have come under intense 
scrutiny as key factors in neoplastic cellular 
growth. In addition, several lines of evidence im- 
plicate cellular (c) proto-oncogenes in the regula- 
tion of proliferation in normal cells. Thus c- 
oncogenes have been highly conserved during 
evolution and there is increased expression of a 
number of different oncogenes during critical 
periods of the cell cycle [2-51. In addition, certain 
c-oncogene products bear a striking homology to 
the epidermal growth factor receptor [6] and 
platelet-derived growth factor [7,8]. With respect 
to the rus family of oncogenes, much less is known 
about the c-ras proto-oncogenes than the transfor- 
ming, v-ras oncogene. Expression of c-Ki-ras is in- 
creased in untransformed 3T3 fibroblasts whose 
transition from the GO to Gr phase of the cell cycle 
is induced by serum [2]. In rats, liver regeneration 
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Oncogene cyclic AMP 
is associated with increased c-Ha-ras expression 
[9]. However we are unaware of data indicating 
specific hormonal regulation of c-rus in non- 
neoplastic cells. 
TSH is the primary regulatory hormone of the 
thyroid gland. Many, but not all, of its diverse ef- 
fects appear to be mediated by CAMP [lo]. While 
the importance of TSH in enhancing the growth of 
normal and neoplastic thyroid tissue is well 
recognized, the mechanism underlying this effect is 
poorly understood. Even the issue of whether or 
not CAMP mediates TSH-induced growth of 
thyroid cells has not been settled conclusively 
[ 1 l-131. Because of the dominant role of TSH in 
the regulation of thyroid cell growth, we therefore 
examined the effect of this hormone on in- 
tracellular levels of c-ras mRNA in a line of dif- 
ferentiated rat thyroid cells (FRTL-5) obtained 
from normal Fischer rat thyroids [14]. 
2. MATERIALS AND METHODS 
FRTL-5 cells were grown in Coon’s modified 
Ham’s F-12 medium supplemented with insulin (10 
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pg/ml), transferrin (5 pg/ml), TSH (1.5 mu/ml), 
penicillin (125 U/ml), gentamycin (40 pg/ml) and 
amphotericin B (2.5 rg/ml). The medium was 
replaced every 3.days. When the lOO-mm diameter 
dishes were approximately half confluent, the cell 
monolayers were washed twice with Dulbecco’s 
phosphate buffered saline (PBS) and the cells were 
then allowed to become quiescent by addition of 
the same medium described above except for the 
omission of TSH. After 5 days of quiescence, a 
maximal stimulatory dose of TSH (10 mu/ml) was 
added to the medium and the incubation was con- 
tinued for the indicated periods of time. The cells 
(30-40 dishes per time point) were rinsed with ice- 
cold PBS and were then solubilized directly on the 
plate with guanidine monothiocyanate [15 1. Total 
RNA was obtained by centrifugation through 5.7 
M CsClz in an SW28 Beckman rotor at 23 000 rpm 
for 20 h. After phenol/chloroform extraction, 
polyadenylated mRNA was obtained by oligo-dT 
affinity chromatography [ 16,171. Thyroid cell 
mRNA concentrations were determined spec- 
trophotometrically and equal aliquots (5 pg per 
lane) were subjected to agarose electrophoresis in 
the presence of methylmercuric hydroxide [18]. 
Ribosomal RNA (E. coli 16 S and 23 S, and calf 
liver 18 S and 28 S) and tRNA were used as stan- 
dards. RNA was transferred by blotting [19] to 
Transa-Bind diazobenzyloxymethyl-paper (DBM) 
[20] (Schleicher and Schuell). v-Ha-ras(SstI-PstI, 
0.7 kb fragment, Pras. 1, sold by Oncor Inc., 
Gaithersburg, MD) and ,&actin DNA probes were 
labelled with [cu-32P]dCTP by nick translation to a 
specific activity of approx. 2 x 10’ cpm/pg [21]. 
After overnight prehybridization, hybridization 
was for 42 h. The final washes were in 1 x SSC 
buffer, 0.1% SDS, at 55°C or 6O”C, depending on 
the background observed on autoradiography 
after an initial wash at 55°C. 
3. RESULTS 
FRTL-5 thyroid cells in monolayer culture were 
made quiescent by the withdrawal of TSH from 
the medium, all other ingredients remaining the 
same. After 5 days, during which time cellular 
growth ceased, TSH (10 mu/ml) was reintro- 
duced. At intervals between 20 min and 24 h 
thereafter, polyadenylated mRNA was prepared 
and c-Ha-ras mRNA levels were determined by 
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Northern blot analysis. Low levels of c-Ha-ras 
mRNA were detectable in quiescent cells. Within 2 
h of TSH stimulation mRNA concentrations in- 
creased to 230% of the control, reached a max- 
imum (730% of the control) after 6 h and then 
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Fig.1. Stimulation by TSH of c-Ha-ras mRNA content 
in FRTL-5 rat thyroid cells. (A) Photograph (302 nm) of 
mRNA in agarose gel prior to blotting, indicating ap- 
proximately equal amounts of mRNA in each lane (5 pg 
in this representative xperiment). The lane on the ex- 
treme left contains the RNA standards. (B) Auto- 
radiography of radiolabelled Ha-rus probe hybridized to 
the mRNA shown in A following transfer to DBM 
paper. (C) Quantification by densitometry (E.C. Ap- 
paratus Corp., St. Petersburg, FL) of the radiolabelled 
Ha-ras hybridized as shown in B. 
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Fig.2. (A) Photograph (302 nm) of mRNA (lOpg/lane) 
following agarose gel electrophoresis. mRNA was ob- 
tained from quiescent (control) cells or from cells expos- 
ed to 1 mM dibutyryl CAMP, 75pM forskolin or 
10 mu/ml TSH for 8 h. The lane on the extreme right 
contains RNA standards. (B) Autoradiograph of radio- 
labelied Ha-ras probe hybridized to DBM paper obtain- 
ed by blotting the gel shown in A. (C) Autoradiograph 
of radiolabelled &actin probe hybridized to DBM paper 
obtained by blotting the agarose gel shown in A. (D) 
Quantification by densitometry of the autoradiographs 
shown in B and C. 
declined to 230% of control after 24 h of TSH 
stimulation (fig. 1). 
To determine whether TSH enh~cement of c- 
Ha-ras mRNA levels in cultured thyroid cells was 
dependent on CAMP as a second messenger, 
FRTL-5 cells were first made quiescent by the 
withdrawal of TSH for 5 days. The cells were then 
exposed to dibutyryl CAMP or to forskolin, which 
directly stimulates adenylate cyclase activity f22] 
independent of interaction with the TSH receptor. 
Both of these agents mimicked TSH action in in- 
creasing the proportion of mRNA transcripts in 
thyroid cells, although to a lesser degree than that 
induced by TSH itself (fig.2B,D). Interestingly, 
while TSH also increased @actin mRNA levels, 
this effect was not mimicked by dibutyryl CAMP 
and forskolin (fig.aC,D). If anything, these agents 
appeared to decrease slightly the relative propor- 
tion of @-actin mRNA. 
4. DISCUSSION 
This study demonstrates hormonal and cyclic 
nucleotide control of c-t-us expression in a well- 
differentiated, non-tumorogenic mammali~ cell. 
FRTL-5 cells are unable to grow in soft-agar, are 
non-tumorogenic when injected into animals, con- 
tain differentiated functions such as iodide 
transport and th~oglobulin synthesis, and do not 
replicate even in full medium containing fetal calf 
serum unless TSH is present 1141. Stimulation by 
TSH of c-m expression precedes by approx. 10 h 
entry into the S phase of the cell cycle, as deter- 
mined by thymidine incorporation in these cells 
[12]. TSH and CAMP therefore produce their ef- 
fect during GO or Gi. 
Our data contrast with the previously observed 
effect of CAMP in decreasing the level of the ~21 
protein product of the rm gene in a line of 
estrogen-dependent mammary carcinoma cells 
1231. However this difference may be related to the 
fact that CAMP stimulates FRTL-5 thyroid cell 
growth [13] but inhibits growth of these mammary 
carcinoma cells 1231. 
It is also of interest hat the stimulatory effect of 
CAMP on c-Ha-ras expression is not a general 
phenomenon for all mRNA types in the thyroid, as 
is evident from the lack of response of @-actin 
mRNA to such stimulation. However, expression 
of at least one other cellular oncogene, myc, is also 
307 
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enhanced by CAMP (and TSH) in cultured thyroid 
cells [24]. Previous evidence has suggested a role 
for c-ras in the regulation of CAMP generation 
(reviewed in [25]). This study adds to this 
remarkable schema by indicating that the reverse 
situation may also exist in specific hormone 
responsive cells, namely that CAMP may regulate 
c-ras expression. 
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